ANN ARBOR, Mich., – July 11, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that the Company has been awarded an increased investment license for expansion of its recombinant spider silk production at Prodigy Textiles, its Vietnamese subsidiary. 

Under the new license, the Vietnamese government increased the Company’s potential investment cap, to as high as $50 million USD.  This significantly increased investment limit will now allow the Company to prepare for the second phase expansion, planned for a 123 acre site located near Prodigy Textiles’ existing facility, and is part of the Company’s systematic and structured plan to expand capacity.

This new license was awarded during a recent trip to Vietnam, taken by the Company’s COO, Jon Rice, to oversee phase one production implementation. After reviewing the progress made under this first phase and meeting with Prodigy Textiles’ president, Vietnamese officials authorized the expansion of the Company investment in scaling up recombinant spider silk production.

“The granting of this expanded license is a demonstration of confidence in Kraig Labs and the potential our eco-friendly spider silk technology has to dramatically alter the global markets for silk and performance textiles,” said Rice. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – July 8, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that the Company will be holding its 2019 annual shareholder meeting on Wednesday, July 24, at 10 a.m. EDT, at the East Lansing Marriott at University place, located at 300 M.A.C. Ave, East Lansing, MI 48823.  The proxy statement containing the meeting details is expected to be mailed no later than July 13 to shareholders of record as of June 12, 2019.

The shareholder meeting is an important step in positioning the Company to advance its business model, including the growth of its spider silk manufacturing operations. 

Shareholders of record of Kraig Labs common stock and preferred stock, as the close of business on June 12, 2019, are entitle to notice of, and to vote at, the meeting.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.  More information on the shareholder meeting will be posted on the Company’s website in the next few days. 

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – June 11, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that a senior member of its leadership team is travelling to Vietnam to oversee operations at the Company’s subsidiary Prodigy Textiles Ltd., construction at the Company’s new facility, and to coordinate the transfer of silkworms from the temporary facility into their permanent home.  Management also anticipates meeting with provincial leaders to discuss further expansion of Prodigy Textiles production.

During this trip, a senior official from Kraig Labs plans to interview and select candidates for several key positions, including operational and financial leadership roles within Prodigy Textiles.  Management has also set aside time to meet with its Vietnamese bankers to outline and discuss a collaborative agreement as Prodigy Textiles prepares to grow rapidly. 

“Work at Prodigy Textiles has been moving quickly as we have continued to direct progress from our U.S. operations.  It is now time for the Company to send someone back to Vietnam in order to oversee the hiring and filling of key positions as we build out our operational leadership team at Prodigy and transition to larger scale silk production,” said COO, Jon Rice.  “I am excited to watch our international team grow as we work together bringing our environmentally sustainable, high performance textiles and yarns to the global markets.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs R&D Team continues to deliver outstanding breakthroughs

ANN ARBOR, Mich., – June 4, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that, in recognition of the magnitude of multiple recent achievements, Dr. Trevor Kane has been promoted to the position of Chief Scientist. 

His successes in creating new transgenics in the lab and expanding our intellectual property portfolio with several new provisional patent applications mark a significant milestone and advancement in Kraig Labs mission to produce and commercialize eco-friendly materials that exceed the performance and strength of native spider silk. 

“These new powerful transgenics, recently created by Dr. Kane’s team, were designed for broad commercial appeal. Dr. Kane has certainly earned his promotion with the successful development of this new architecture. This next generation technology, developed in our labs, has the potential to radically advance gains in material performance, above and beyond anything we’ve previously produced,” said CEO and Founder, Kim Thompson.

“I would like congratulate and commend Dr. Kane and our entire R&D team for their success in developing these breakthrough technologies,” said COO Jon Rice.

These new transgenics incorporate several technologies covered by the Company’s recent provisional patent applications and set the stage for new commercial applications. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Innovation from Kraig Labs R&D Team delivers next generation Spider Silk

ANN ARBOR, Mich., – May 30, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today the creation of the next generation of recombinant spider silk using the Company’s new design, gene editing, and incorporation approaches. Kraig Labs designed this approach to customize mechanical properties for specific commercial markets and has demonstrated the ability to more quickly, accurately, and efficiently, generate new transgenics. 

This is the material science breakthrough that the Company has been pushing for since establishing the Dragon Silk line; this new transgenic was specifically engineered for high strength and significantly higher protein expression levels. This achievement marks a significant milestone in Kraig Labs’ mission to produce and commercialize eco-friendly materials that exceed the performance and strength of native spider silk. 

“This breakthrough has powerful ramifications that affect the core of how we develop future spider silk materials,” said COO Jon Rice.  “These newly confirmed transgenics mark a revolutionary advancement in capability of our spider silk materials. The new tools developed by Dr. Kane and our research team will allow us to target commercial markets that were not originally on our radar.”

Screening of these samples confirms that the gene edit was successful, validating the underlying protocols and genetic constructs.  Furthermore, western blot analysis, performed on the silk, confirms expression of this new and potentially much more powerful spider silk protein. These results open the door for the Company to deploy this new methodology towards a variety of tailored spider silk designs. Kraig Labs expects these new recombinant spider silk fiber lines will open up broader commercial opportunities and complement the Company’s existing Monster Silk™ and Dragon Silk™ technologies.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – May 22, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has submitted five new provisional patent applications, for technologies related to its recombinant spider silk technologies.  These applications cover a broad range of technologies in the creation, screening, and production of new recombinant proteins.  These new applications expand beyond the Company’s publicly disclosed silkworm and silk technologies, to include advanced construction systems, methods, and non-native proteins. 

In November, of 2018, the Company retained Workman Nydegger as its Intellectual Property counsel and expects to utilize their expertise in prosecuting these, and all future, patent applications.

“Our R&D team is constantly looking for opportunities to strengthen our competitive potions, products, and processes. The recently submitted provisional patent applications cover key technologies and processes, invented by Dr. Kane and our team, as well as new applications that build upon our technologies,” said Kraig’s COO Jon Rice.  “These new technologies have the potential to significantly reduce future R&D costs and break open new markets for recombinant protein products, reaching far beyond silks and apparel.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news. 

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – May 20, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its subsidiary Prodigy Textiles has taken possession of its factory in Vietnam.  The Company is now retrofitting the nearly 50,000 square foot facility to produce its game changing recombinant spider silk materials.   Remodeling efforts are expected to be minimal and completed quickly.  This facility was selected based on its optimal layout and existing infrastructure. 

“Our people on the ground, in Vietnam, are wasting no time getting this facility into operation.  We have outlined a very aggressive timeline for bringing the factory online and we are monitoring progress daily,” said Kraig’s COO Jon Rice.  “We are very pleased to see how quickly things are moving and look forward to completing the transition.  We expect to make delivery of the first production batch, of our recombinant spider silk thread, from this factory to one of our strategic market channel partners in the third or fourth quarter.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news. 

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs opens R&D headquarters to media for the first time

ANN ARBOR, Mich., – May 13, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its recombinant spider silk technology will be featured in a documentary focused on combating terrorism.  The Company opened the doors of its R&D headquarters, for the first time to the media, to host a French documentary film crew and provided them with access to the process of creating its incredible spider silk technologies.

Tougher and more flexible than competing materials, spider silk offers the promise of increased protection, comfort, and mobility in protective textile applications. In addition to this documentary, the Company has been covered by numerous media outlets, including the following T.EVO, Textile Evolution, article; https://www.tevonews.com/fibres-yarns-news/2026-polartec-figureheads-discuss-kraig-labs-silkworm-solution.

“Our team is incredibly proud of the work we do here and the impact that our Company is already making in these important markets,” said COO Jon Rice.  “It was a pleasure to be able to share the results of our efforts and to showcase this amazing technology along with its potential to disrupt the protective textile and related markets.”

The series is planned to air in the fall of 2019.  Although the footage was shot at Kraig Labs’ R&D headquarters in Michigan, the Company continues to focus its efforts on scaling up its production operations, through its subsidiary, Prodigy Textiles Ltd., in Asia.  By utilizing the existing global silk infrastructure and Kraig Labs’ engineered silkworm technology, the Company set to meet cost and volume metrics, previously thought to be impossible, in the commercialization of spider silk for these lifesaving applications in protective textiles.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs signs factory lease to expand production capacity

ANN ARBOR, Mich., – May 7, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that, through its subsidiary Prodigy Textiles, the Company has signed a new 5 year lease on a factory, expanding its production footprint in Vietnam.  The roughly 50,000 ft² facility in Quang Nam province is expected to play a major role in supporting the Company’s increasing production capacity of its proprietary recombinant spider silk technologies.

“Our team in Vietnam, led by Mr. Kenneth Le, has done an excellent job of scouting, selecting, and negotiating the terms of this deal.  With its close proximity to the necessary mulberry fields, and easy access to shipping ports, this facility will serve as a springboard for Kraig Labs introduction of spider silk into the global textile markets,” said COO Jon Rice.

The Company expects to begin transferring its technology into the larger factory from the temporary facility that Prodigy Textiles has been utilizing since December of 2018.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Additional independent directors to help advance Kraig Labs’ business model

ANN ARBOR, Mich., – April 29, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has initiated the process of identifying qualified corporate leaders, to assist in the Company’s growth, as it plans to add two new independent corporate board directors.

“With the successful delivery of our proprietary spider silk technology to Prodigy Textiles, our Vietnamese subsidiary, we are now moving into the production phase of our business plan. We believe that this is the right moment to bring on additional expertise to support the Company’s efforts to bring spider silk to the performance textile markets.   The addition of these new board members will assist our growth through this exciting transition to commercialization and help keep our focus on continuing to create shareholder value,” stated COO, Jon Rice. 

Expanding the Board of Directors is an important advancement in Kraig Labs’ business model and is an important milestone for the Company as it contemplates uplisting to a larger exchange.

“We plan to conduct a careful search, to identify independent board members who can contribute expertise and crucial market experience, as we look to rapidly grow our capacity and expand our strategic market channel partner networks,” said CEO and Founder, Kim Thompson. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com